1. Home
  2. MBX vs AII Comparison

MBX vs AII Comparison

Compare MBX & AII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBX
  • AII
  • Stock Information
  • Founded
  • MBX 2018
  • AII 2006
  • Country
  • MBX United States
  • AII United States
  • Employees
  • MBX N/A
  • AII N/A
  • Industry
  • MBX
  • AII Property-Casualty Insurers
  • Sector
  • MBX
  • AII Finance
  • Exchange
  • MBX NYSE
  • AII Nasdaq
  • Market Cap
  • MBX 379.7M
  • AII 315.3M
  • IPO Year
  • MBX 2024
  • AII 2025
  • Fundamental
  • Price
  • MBX $9.63
  • AII $16.70
  • Analyst Decision
  • MBX Strong Buy
  • AII Buy
  • Analyst Count
  • MBX 5
  • AII 3
  • Target Price
  • MBX $37.40
  • AII $21.50
  • AVG Volume (30 Days)
  • MBX 217.8K
  • AII 129.7K
  • Earning Date
  • MBX 08-16-2025
  • AII 01-01-0001
  • Dividend Yield
  • MBX N/A
  • AII N/A
  • EPS Growth
  • MBX N/A
  • AII N/A
  • EPS
  • MBX N/A
  • AII 3.19
  • Revenue
  • MBX N/A
  • AII $231,932,000.00
  • Revenue This Year
  • MBX N/A
  • AII N/A
  • Revenue Next Year
  • MBX N/A
  • AII N/A
  • P/E Ratio
  • MBX N/A
  • AII $5.25
  • Revenue Growth
  • MBX N/A
  • AII 1.73
  • 52 Week Low
  • MBX $4.81
  • AII $15.78
  • 52 Week High
  • MBX $27.50
  • AII $19.45
  • Technical
  • Relative Strength Index (RSI)
  • MBX N/A
  • AII N/A
  • Support Level
  • MBX N/A
  • AII N/A
  • Resistance Level
  • MBX N/A
  • AII N/A
  • Average True Range (ATR)
  • MBX 0.00
  • AII 0.00
  • MACD
  • MBX 0.00
  • AII 0.00
  • Stochastic Oscillator
  • MBX 0.00
  • AII 0.00

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

About AII American Integrity Insurance Group Inc. Common Stock

American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.

Share on Social Networks: